Abstract
Abstract Radiation therapy as primary treatment for lymphosarcoma and giant follicle lymphoma in 62 patients was evaluated for the rate of recurrence in treated areas as the first manifestation of relapse. For lymphosarcoma, local recurrence was prevented by 3,500 rads tumor dose or more in four weeks. Giant follicle lymphoma did not recur after radiotherapy with more than 2,000 rads tumor dose in ten to twenty-one days. The five-year survival of lymphosarcoma patients was higher when treated with the higher dose of radiation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
